MFHAS1 and COVID-19: On the other hand, higher methylation of PSMB9, MRPS2, MFHAS1, and MAT2B genes are known to be expressed in COVID-19 patients with high viral load or severe infection [57–61], which could translate to a lower expression of those genes.